Arcturus Therapeutics Reports Q2 2026 Results

What Happened

• On August 6, 2026 Arcturus Therapeutics Holdings, Inc. (Arcturus) filed a Form 8-K (Item 2.02) furnishing a press release that announces the company’s financial results for the quarter ended June 30, 2026 and provides a corporate update. The press release is included as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02).
• Period covered: quarter ended June 30, 2026 (quarterly results / earnings announcement).
• Press release furnished as Exhibit 99.1; the cover page is provided in Inline XBRL (Exhibit 104).
• The 8-K conveys the company’s earnings/financial results and a corporate update (specific financial figures should be read in the attached press release).

Why It Matters

• This 8-K is the company’s official disclosure of its recent quarterly results and any corporate developments — essential for investors tracking Arcturus’ earnings, revenue trends, cash position, or updates to programs and guidance.
• Investors should review the Exhibit 99.1 press release and any subsequent filings for the specific numbers (revenue, net income/loss, cash runway, or guidance) before making investment decisions.